Buscar
Mostrando ítems 21-30 de 415
Long-acting antiretroviral therapy
Nanoformulations of cabotegravir prodrugs have been developed to prolong the pharmacokinetics of the
antiretroviral agent. They can be present in the plasma of mice and non-human primates for a year following
a single injection.
Pontine reversible leucopathy in an AIDS patient associated with highly active antiretroviral therapy (HAART). report of one case Leucopatía reversible de la protuberancia: En paciente con SIDA y tratamiento retroviral
(Sociedad Medica de Santiago, 2016)
© 2016, Sociedad Medica de Santiago. All Rights Reserved. Posterior reversible encephalopathy (PRES) is a condition characterized by T2 and FLAIR hyperintensities in magnetic resonance imaging (MRI) studies, localized ...
Severe manifestation of Leishmaniasis in HIV co-infected individuals manifested as immune reconstitution of inflammatory syndrome (IRIS)
(Sociedade Brasileira de Parasitologia, 2020)
Evaluation of inadequate anti-retroviral treatment in patients with HIV/AIDS
(SOC BRASILEIRA MEDICINA TROPICALBRASILIA, 2012)
Introduction: Since the emergence of antiretroviral therapy, the survival of patients infected with human immunodeficiency virus has increased. Non-adherence to this therapy is directly related to treatment failure, which ...
Self-perception of knowledge and adherence reflecting the effectiveness of antiretroviral therapy
(2016-09-13)
Objectives: To evaluate which indirect method for assessing adherence best reflects highly active antiretroviral therapy (HAART) effectiveness and the factors related to adherence. Method: This descriptive, cross-sectional ...
Resistencia a la terapia antirretroviral en pacientes infectados con el virus VIH-1 en Chile 2002-2005
(Sociedad Médica de Santiago, 2007)
Factores asociados a la evolución del recuento de linfocitos CD4 como marcador de la respuesta inmunológica en los pacientes naive adultos VIH positivos que reciben tratamiento antiretroviral (TARGA) en el Perú
(Universidad Nacional Mayor de San MarcosPE, 2007)
Determina la asociación del sexo, edad, tipo de esquema de tratamiento antiretroviral, carga viral basal y supresión virológica temprana al tercer mes, con la evolución del recuento de linfocitos CD4 en los pacientes adultos ...